OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Biotechnology is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models	279
Advisory Board and Contents	242
Human Blood–Brain Barrier on a Chip: Featuring Unique Multicellular Cooperation in Pathophysiology	238
Subscription and Copyright information	224
Healing wounds with plasma-activated hydrogel therapy	173
Vector-free intra-airway in vivo epigenetic editing	138
Microalgae: a revolution for salt-affected soil remediation	136
Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications	132
Smart Nucleic Acids as Future Therapeutics	122
Designing Artificial Cells towards a New Generation of Biosensors	118
Electronic plants: the future of agriculture and urban ecosystems?	114
Analyzing and understanding the robustness of bioprocesses	110
Potency Meets Precision in Nano-optimized Chemotherapeutics	109
Auricular repair: symphony between scaffolds and stem cells	108
Engineering biology approaches to modulate bacterial biofilms	98
Vibrio natriegens as a host for rapid biotechnology	94
SynMADE: synthetic microbiota across diverse ecosystems	92
Manipulating immune activity of macrophages: a materials and mechanics perspective	85
Phytohormones: novel strategy for removing emerging contaminants and recovering resources	84
(R)evolution-on-a-chip	83
Food Waste: A Promising Source of Sustainable Biohydrogen Fuel	82
The green revolution of food waste upcycling to produce polyhydroxyalkanoates	80
Smart materials: rational design in biosystems via artificial intelligence	80
Enzyme discovery and engineering for sustainable plastic recycling	79
Advisory Board and Contents	77

Prime editing: advances and therapeutic applications	77
Advisory Board and Contents	74
Subscription and Copyright information	71
Towards biomanufacturing of cultured meat	70
Subscription and Copyright information	70
Machine learning to predict de novo protein–protein interactions	69
Can protein expression be ‘solved’?	69
Mini-bones: miniaturized bone in vitro models	68
Beyond waste: understanding urine’s potential in precision medicine	67
The GPS for drug development: navigating with evidence from human populations	66
UFSC Biotech Network: a transdisciplinary platform for biotechnology innovation in Brazil	66
Emerging strategies to develop novel genetically encoded biosensors	65
Translational organoid technology – the convergence of chemical, mechanical, and computational biology	64
Multiscale models quantifying yeast physiology: towards a whole-cell model	64
Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices	64
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases	64
A high-performance protein preparation approach in a single column-free step	64
Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions	63
Printhead on a chip: empowering droplet-based bioprinting with microfluidics	62
Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis	59
Molecular design of microalgae as sustainable cell factories	59
Machine learning in bioprocess development: from promise to practice	59
Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia	59
Manufacturing innovation to drive down cell therapy costs	59
Multienzymatic synthesis of nylon monomers from vegetable oils	56
Subscription and Copyright information	56
3D printing of heart valves	56
Sebum analysis as an advantageous source of biomolecular information	56
Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy	55
Advisory Board and Contents	55
Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance	55